Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029
Clinical trial NCT01938482 · COMPLETED
Trial details
- NCT number
- NCT01938482
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-31
- Primary completion
- 2015-02-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.